
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
Joyonna Gamble‐George, Rita Báldi, Lindsay R. Halladay, et al.
eLife (2016) Vol. 5
Open Access | Times Cited: 50
Joyonna Gamble‐George, Rita Báldi, Lindsay R. Halladay, et al.
eLife (2016) Vol. 5
Open Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Role of oxidative stress in depression
Shvetank Bhatt, Anantha Naik Nagappa, Chandragouda R. Patil
Drug Discovery Today (2020) Vol. 25, Iss. 7, pp. 1270-1276
Closed Access | Times Cited: 530
Shvetank Bhatt, Anantha Naik Nagappa, Chandragouda R. Patil
Drug Discovery Today (2020) Vol. 25, Iss. 7, pp. 1270-1276
Closed Access | Times Cited: 530
The cannabinoid system and pain
Stephen G. Woodhams, Victoria Chapman, David P. Finn, et al.
Neuropharmacology (2017) Vol. 124, pp. 105-120
Open Access | Times Cited: 239
Stephen G. Woodhams, Victoria Chapman, David P. Finn, et al.
Neuropharmacology (2017) Vol. 124, pp. 105-120
Open Access | Times Cited: 239
The endocannabinoid system as a target for novel anxiolytic drugs
Sachin Patel, Mathew N. Hill, Joseph F. Cheer, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 76, pp. 56-66
Open Access | Times Cited: 222
Sachin Patel, Mathew N. Hill, Joseph F. Cheer, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 76, pp. 56-66
Open Access | Times Cited: 222
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 206
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 206
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder
Matthew N. Hill, Patrizia Campolongo, Rachel Yehuda, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 80-102
Open Access | Times Cited: 202
Matthew N. Hill, Patrizia Campolongo, Rachel Yehuda, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 80-102
Open Access | Times Cited: 202
The role of the immune system in posttraumatic stress disorder
Şeyma Katrinli, Nayara Cristina dos Santos Oliveira, Jennifer C. Felger, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 86
Şeyma Katrinli, Nayara Cristina dos Santos Oliveira, Jennifer C. Felger, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 86
Metabolism, Metabolomics, and Inflammation in Posttraumatic Stress Disorder
Synthia H. Mellon, Aarti Gautam, Rasha Hammamieh, et al.
Biological Psychiatry (2018) Vol. 83, Iss. 10, pp. 866-875
Open Access | Times Cited: 161
Synthia H. Mellon, Aarti Gautam, Rasha Hammamieh, et al.
Biological Psychiatry (2018) Vol. 83, Iss. 10, pp. 866-875
Open Access | Times Cited: 161
Epigenome-wide meta-analysis of PTSD across 10 military and civilian cohorts identifies methylation changes in AHRR
Alicia K. Smith, Andrew Ratanatharathorn, Adam X. Maihofer, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 115
Alicia K. Smith, Andrew Ratanatharathorn, Adam X. Maihofer, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 115
Enhanced endocannabinoid tone as a potential target of pharmacotherapy
Marek Toczek, Barbara Malinowska
Life Sciences (2018) Vol. 204, pp. 20-45
Closed Access | Times Cited: 95
Marek Toczek, Barbara Malinowska
Life Sciences (2018) Vol. 204, pp. 20-45
Closed Access | Times Cited: 95
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety
Gaurav Bedse, Nolan D. Hartley, Emily Neale, et al.
Biological Psychiatry (2017) Vol. 82, Iss. 7, pp. 488-499
Open Access | Times Cited: 94
Gaurav Bedse, Nolan D. Hartley, Emily Neale, et al.
Biological Psychiatry (2017) Vol. 82, Iss. 7, pp. 488-499
Open Access | Times Cited: 94
Cannabinoid Regulation of Fear and Anxiety: an Update
Eleni P. Papagianni, Carl W. Stevenson
Current Psychiatry Reports (2019) Vol. 21, Iss. 6
Open Access | Times Cited: 94
Eleni P. Papagianni, Carl W. Stevenson
Current Psychiatry Reports (2019) Vol. 21, Iss. 6
Open Access | Times Cited: 94
The Role of Brain Cyclooxygenase-2 (Cox-2) Beyond Neuroinflammation: Neuronal Homeostasis in Memory and Anxiety
Diana López Ramos, Santiago Ballaz
Molecular Neurobiology (2020) Vol. 57, Iss. 12, pp. 5167-5176
Closed Access | Times Cited: 86
Diana López Ramos, Santiago Ballaz
Molecular Neurobiology (2020) Vol. 57, Iss. 12, pp. 5167-5176
Closed Access | Times Cited: 86
Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities
Mark D. Namba, Jonna M. Leyrer‐Jackson, Erin K. Nagy, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 56
Mark D. Namba, Jonna M. Leyrer‐Jackson, Erin K. Nagy, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 56
Targeting inflammation: a potential approach for the treatment of depression
Shvetank Bhatt, Thangaraj Devadoss, Niraj Kumar Jha, et al.
Metabolic Brain Disease (2022) Vol. 38, Iss. 1, pp. 45-59
Closed Access | Times Cited: 49
Shvetank Bhatt, Thangaraj Devadoss, Niraj Kumar Jha, et al.
Metabolic Brain Disease (2022) Vol. 38, Iss. 1, pp. 45-59
Closed Access | Times Cited: 49
Neuroinflammation in Post-Traumatic Stress Disorder
Dong-Hun Lee, Ji-Young Lee, Dong-Yong Hong, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 953-953
Open Access | Times Cited: 42
Dong-Hun Lee, Ji-Young Lee, Dong-Yong Hong, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 953-953
Open Access | Times Cited: 42
Innate and adaptive immune system consequences of post-traumatic stress disorder
Tatlock H. Lauten, Tamara Natour, Adam J. Case
Autonomic Neuroscience (2024) Vol. 252, pp. 103159-103159
Closed Access | Times Cited: 8
Tatlock H. Lauten, Tamara Natour, Adam J. Case
Autonomic Neuroscience (2024) Vol. 252, pp. 103159-103159
Closed Access | Times Cited: 8
Prefrontal Regulation of Punished Ethanol Self-administration
Lindsay R. Halladay, Adrina Kocharian, Patrick T. Piantadosi, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 11, pp. 967-978
Open Access | Times Cited: 69
Lindsay R. Halladay, Adrina Kocharian, Patrick T. Piantadosi, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 11, pp. 967-978
Open Access | Times Cited: 69
Posttraumatic Stress Disorder: An Immunological Disorder?
Zhewu Wang, Blaine Caughron, Matthew R. Young
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 66
Zhewu Wang, Blaine Caughron, Matthew R. Young
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 66
Cannabinoid interventions for PTSD: Where to next?
Luke J. Ney, Allison Matthews, Raimondo Bruno, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 93, pp. 124-140
Closed Access | Times Cited: 61
Luke J. Ney, Allison Matthews, Raimondo Bruno, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 93, pp. 124-140
Closed Access | Times Cited: 61
A role for the mu opioid receptor in the antidepressant effects of buprenorphine
Shivon A. Robinson, Rebecca L. Erickson, Caroline A. Browne, et al.
Behavioural Brain Research (2016) Vol. 319, pp. 96-103
Open Access | Times Cited: 53
Shivon A. Robinson, Rebecca L. Erickson, Caroline A. Browne, et al.
Behavioural Brain Research (2016) Vol. 319, pp. 96-103
Open Access | Times Cited: 53
Deciphering the mechanisms of reciprocal regulation or interdependence at the cannabinoid CB1 receptors and cyclooxygenase-2 level: Effects on mood, cognitive implications, and synaptic signaling
Katarzyna Stachowicz
Neuroscience & Biobehavioral Reviews (2023) Vol. 155, pp. 105439-105439
Closed Access | Times Cited: 9
Katarzyna Stachowicz
Neuroscience & Biobehavioral Reviews (2023) Vol. 155, pp. 105439-105439
Closed Access | Times Cited: 9
Decreased Prostaglandin D2 Levels in Major Depressive Disorder Are Associated with Depression-Like Behaviors
Cuilin Chu, Hui Wei, Wanwan Zhu, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 20, Iss. 9, pp. 731-739
Open Access | Times Cited: 31
Cuilin Chu, Hui Wei, Wanwan Zhu, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 20, Iss. 9, pp. 731-739
Open Access | Times Cited: 31
Cyclooxygenase-2 inhibition reduces anxiety-like behavior and normalizes enhanced amygdala glutamatergic transmission following chronic oral corticosterone treatment
Amanda Morgan, Veronika Kondev, Gaurav Bedse, et al.
Neurobiology of Stress (2019) Vol. 11, pp. 100190-100190
Open Access | Times Cited: 26
Amanda Morgan, Veronika Kondev, Gaurav Bedse, et al.
Neurobiology of Stress (2019) Vol. 11, pp. 100190-100190
Open Access | Times Cited: 26
Phasic signaling in the bed nucleus of the stria terminalis during fear learning predicts within- and across-session cued fear expression
Max Bjorni, Natalie G. Rovero, Elissa R. Yang, et al.
Learning & Memory (2020) Vol. 27, Iss. 3, pp. 83-90
Open Access | Times Cited: 23
Max Bjorni, Natalie G. Rovero, Elissa R. Yang, et al.
Learning & Memory (2020) Vol. 27, Iss. 3, pp. 83-90
Open Access | Times Cited: 23
A Fast-Binding, Functionally Reversible, COX-2 Radiotracer for CNS PET Imaging
Michael S. Placzek, Daniel K. Wilton, Michel Weïwer, et al.
ACS Central Science (2024) Vol. 10, Iss. 5, pp. 1105-1114
Open Access | Times Cited: 2
Michael S. Placzek, Daniel K. Wilton, Michel Weïwer, et al.
ACS Central Science (2024) Vol. 10, Iss. 5, pp. 1105-1114
Open Access | Times Cited: 2